Monday, November 6, 2017
- 9:00AM-11:00AM
-
Abstract Number: 1558
Changes in Blood Pressure with TNF Inhibitors for Psoriatic Arthritis
Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster II- 9:00AM-11:00AM
-
Abstract Number: 1627
Changes in Heart Rate Variability Reflect Changes in Clinical Status and Patient Reported Outcomes in Systemic Lupus Erythematosus: A Longitudinal Analysis
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 1467
Changes in the Immune Response of RA Patients Induced By 1 Year of Tocilizumab
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster II: Prognostic Factors, Imaging and Miscellaneous Reports- 9:00AM-11:00AM
-
Abstract Number: 1309
Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database
Reproductive Issues in Rheumatic Disorders Poster- 9:00AM-11:00AM
-
Abstract Number: 1525
Characteristics and Treatment Patterns Among Patients with Psoriatic Arthritis Initiating Subcutaneously Administered Biologics: Descriptive Analyses from a US Claims Database
Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster II- 9:00AM-11:00AM
-
Abstract Number: 1493
Characteristics of Korean Primary Sjogren’s Syndrome and Comparison of 3 Different Classification Criteria for Primary Sjogren’s Syndrome: Data from Korean Kiss Cohort
Sjögren's Syndrome Poster II: Clinical Research- 9:00AM-11:00AM
-
Abstract Number: 1419
Characteristics of Patients with Early Rheumatoid Arthritis Who Have a Delayed Response to Treatment with Methotrexate in Monotherapy or in Combination with Adalimumab
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster II: Prognostic Factors, Imaging and Miscellaneous Reports- 9:00AM-11:00AM
-
Abstract Number: 1382
Characteristics of Patients with Rheumatoid Arthritis and Atlanto-Axial Pannus
Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures- 9:00AM-11:00AM
-
Abstract Number: 1064
Characterization of Human Tolerogenic Dendritic Cells Generated with Protein Kinase C Inhibitor and Induction from Patients with Autoimmune Diseases
Innate Immunity and Rheumatic Disease Poster II- 9:00AM-11:00AM
-
Abstract Number: 1215
Chest Radiography As a Screening Tool to Detect Fragile Spine Fractures
Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1754
Childhood- Vs. Adult-Onset ANCA-Associated Vasculitides: A Nested, Matched Case–Control Study from the French Vasculitis Study Group Registry
Vasculitis Poster II: ANCA-Associated Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 1626
Childhood-Onset Predicts Increased Steroid-Related Damage Among Adults with Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 1251
Chinese Patient Reported Index with Rheumatoid Arthritis (CPRI-RA): Reliability, Validity and Agreement with DAS28 and HAQ
Patient Outcomes, Preferences, and Attitudes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1584
Chlamydia-Infected Macrophages: “Trojan Horses” for Dissemination of IL-23 and TNF-Mediated Inflammation in SKG Mouse Reactive Arthritis